3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
4
CNS
4
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
10
Pancreatic Neoplasms
9
Neoplasm Metastasis
5
Breast Neoplasms
5
Melanoma
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Lymphoma
3
Lung Neoplasms
3
Liver Neoplasms
3
Carcinoma, Renal Cell
3
Wilms Tumor
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Neuroblastoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms
2
Kidney Neoplasms
2
Astrocytoma
2
Adenomatous Polyposis Coli
2
Thyroid Neoplasms
1
Thrombocytosis
1
Somatostatinoma
1
Sarcoma, Clear Cell
1
Retinoblastoma
1
Interventions
Magnetic Resonance Spectroscopy
11
Specimen Handling
8
X-Rays
7
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Biopsy
6
olaparib
4
ulixertinib
3
trametinib
3
palbociclib
3
larotrectinib
3
ivosidenib
3
erdafitinib
3
dabrafenib
3
Vemurafenib
3
tipifarnib
2
tazemetostat
2
selpercatinib
2
ensartinib
2
durvalumab
2
Nivolumab
2
LY3023414
2
Gemcitabine
2
Doxorubicin
2
Docetaxel
2
Cisplatin
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
sonidegib
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioma
×
Sirolimus
×
Gastrointestinal
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled